New: NCI-funded clinical trial search
Mednet Logo

How do you define treatment-resistant depression in your practice?

What strategies do you use to counsel patients on continuing an antidepressant until therapeutic doses versus switching agents if they perceive a lack of, or incomplete, benefit?
1 Answer
Mednet MemberInvited Expert
Primary Care · University of Colorado
Answered on

Well, technically, treatment-resistant depression is defined as no meaningful response after at least two trials of antidepressants at therapeutic doses and durations (≥8 weeks). The first step is to rule out inadequate dosing (try to reach the max dose), poor adherence, and medical comorbidities that could be causing overlapping symptoms.

For patients with a true incomplete or absent response, I usually make sure they are getting therapy (alwasy a good idea and most effective), and then offer augmentation with either a second-generation antipsychotic, second generation andidepressant, or switching primary agents (although, if there is any response at all, even a slight, partial one, I favor augmentation). If that doesn't work, then I will ...

Join for free or sign in to see the full answer